Costa Rica vs Oman: Cancer death rate by age group
Costa Rica
0 deaths per 100,000 people
in 2022
Oman
0 deaths per 100,000 people
in 2021
Costa Rica rank
77th
Oman rank
77th
Cancer death rate by age group over time
- Costa Rica
- Oman
How they compare
Costa Rica currently reports 0 deaths per 100,000 people against 0 deaths per 100,000 people in Oman, a difference of 0 deaths per 100,000 people.
The two have swapped places 2 times across 9 shared years of data; in 2009 it was Oman ahead.
Costa Rica ranks 77th and Oman ranks 77th of 111 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Costa Rica | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.38 deaths per 100,000 people | 3.2 deaths per 100,000 people | 1.82 deaths per 100,000 people | Oman |
| 2010s | 2.55 deaths per 100,000 people | 0.5929 deaths per 100,000 people | 1.96 deaths per 100,000 people | Costa Rica |
| 2020s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rate by age group, Costa Rica or Oman?
- Costa Rica, at 0 deaths per 100,000 people against 0 deaths per 100,000 people in Oman as of 2022.
- What is the difference in cancer death rate by age group between Costa Rica and Oman?
- 0 deaths per 100,000 people, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Oman?
- 9 years are reported by both, from 2009 to 2021.
- How do Costa Rica and Oman rank globally for cancer death rate by age group?
- Costa Rica ranks 77th and Oman ranks 77th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rate by age group. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged less than 1 year.